v3.26.1
PREFERRED STOCK AND COMMON SHAREHOLDERS' EQUITY
 6 Months Ended
Jun. 30, 2026
Stockholders' Equity Note [Abstract]  
PREFERRED SSTOCK AND COMMON SHAREHOLDERS' EQUITY PREFERRED STOCK AND COMMON SHAREHOLDERS’ EQUITY
The Company is authorized to issue up to 265.0 shares of its Common Stock. The Company is authorized to issue up to 30.0 shares of preferred stock, par value $0.10 per share. There were no preferred shares outstanding at June 30, 2026, and December 31, 2025.
The changes in the Company’s shares of Common Stock issued and outstanding are summarized below:
Six Months Ended June 30, 2026
Beginning balance82.2 
      Shares issued under employee stock plans0.4 
      Shares repurchased(1.7)
Ending balance
80.9 
Share Repurchase Program
The Company has entered and may continue to enter into Rule 10b5-1 plans from time to time to facilitate repurchases of its Common Stock. During the six months ended June 30, 2026, the Company purchased 1.7 shares of its Common Stock at an average price of $263.12 per share for a total cost of $451.8. During the six months ended June 30, 2025, the Company purchased 0.8 shares of its Common Stock at an average price of $246.18 per share for a total cost of $200.0. At June 30, 2026,
the Company had outstanding authorization from its Board to purchase up to $378.6 maximum value of shares of Common Stock.
On July 8, 2026, the Board authorized the repurchase of an additional $1,000.0 in the maximum value of the Company’s shares of Common Stock as part of the Company’s ongoing share repurchase program, bringing the total share repurchase authorization to $1,378.6 maximum value of shares of Common Stock. The repurchase authorization has no expiration date.
When the Company repurchases shares of Common Stock, the amount paid to repurchase the shares in excess of the par or stated value is allocated to Additional paid-in-capital within the Condensed Consolidated Balance Sheet unless subject to limitation or the balance in Additional paid-in-capital is exhausted. Remaining amounts are recognized as a reduction in Retained earnings within the Company’s Condensed Consolidated Balance Sheet.
Dividends
During each of the three months ended June 30, 2026, and 2025, and each of the six months ended June 30, 2026, and 2025, the Company declared and paid a cash dividend of $0.72 and $1.44, respectively, per share of Common Stock.
On July 9, 2026, the Company announced a cash dividend of $0.72 per share of Common Stock, or approximately $59.0 in the aggregate. The dividend will be paid on September 11, 2026, to stockholders of record of all issued and outstanding shares of Common Stock as of the close of business on August 28, 2026. The declaration and payment of any future dividends will be at the discretion of the Board.
Accumulated Other Comprehensive Loss
The components of Accumulated other comprehensive loss were as follows:
Foreign Currency Translation AdjustmentsNet Benefit Plan AdjustmentsAccumulated Other Comprehensive Loss
Balance at December 31, 2024$(264.7)$3.1 $(261.6)
  Current year adjustments69.7 0.4 70.1 
  Tax effect on adjustments— (0.1)(0.1)
Balance at March 31, 2025(195.0)3.4 (191.6)
  Current year adjustments156.6 0.5 157.1 
  Tax effect on adjustments— (0.1)(0.1)
Balance at June 30, 2025$(38.4)$3.8 $(34.6)
Balance at December 31, 2025$(33.0)$5.4 $(27.6)
  Current year adjustments(36.0)0.5 (35.5)
  Tax effect on adjustments— (0.1)(0.1)
Balance at March 31, 2026(69.0)5.8 (63.2)
  Current year adjustments(39.1)0.5 (38.6)
  Tax effect of adjustments— (0.1)(0.1)
Balance at June 30, 2026$(108.1)$6.2 $(101.9)